Academic Pediatrics
Volume 9, Issue 5 , Pages 348-352 , September 2009

Parents' Views on 3 Shot-Related Visits: Implications for Use of Adolescent Vaccines Like Human Papillomavirus Vaccine

  • Amanda F. Dempsey, MD, PhD, MPH

      Affiliations

    • Corresponding Author InformationAddress correspondence to Amanda F. Dempsey, MD, PhD, MPH, Child Health Evaluation and Research Unit, Department of Pediatrics, University of Michigan, 300 North Ingalls, Rm 6E08, Ann Arbor, Michigan 48109-5456.
    • ,
  • Dianne Singer, MPH
    • ,
  • Sarah J. Clark, MPH
    • ,
  • Matthew M. Davis, MD, MAPP

Received 24 October 2008 ,Accepted 10 April 2009.

References 

  1. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1–21
  2. Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–34
  3. Broder KR, Cohn AC, Schwartz B, et al. Adolescent immunizations and other clinical preventive services: a needle and a hook?. Pediatrics. 2008;12(suppl 1):S25–S34
  4. Gardasil [product information sheet]. Whitehouse Station, NJ: Merck & Co; 2006.
  5. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–24
  6. Giuliano AR, Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: point. Cancer Epidemiol Biomarkers Prev. 2008;17:805–808
  7. Rand CM, Szilagyi PG, Albertin C, Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatrics. 2007;120:461–466
  8. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002;347:1652–1661
  9. Wloch MK, Smith LR, Boutsaboualoy S, et al. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis. 2008;197:1634–1642
  10. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117:1486–1493
  11. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58:1405–1413
  12. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37:248–251
  13. Gerend MA, Shepherd JE, Monday KA. Behavioral frequency moderates the effects of message framing on HPV vaccine acceptability. Ann Behav Med. 2008;35:221–229
  14. Kahn JA, Rosenthal SL, Jin Y, et al. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008;111:1103–1110
  15. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ. 2008;336:1056–1058
  16. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43:239–245
  17. McCauley MM, Stokley S, Stevenson J, Fishbein DB. Adolescent vaccination: coverage achieved by ages 13–15 years, and vaccinations received as recommended during ages 11–12 years, national health interview survey 1997–2003. J Adolesc Health. 2008;43:540–547
  18. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13–17 years—United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:1100–1103
  19. Zimet GD, Mays RM, Sturm LA, et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med. 2005;159:132–137
  20. Bair RM, Mays RM, Sturm LA, et al. Acceptability to Latino parents of sexually transmitted infection vaccination. Ambul Pediatr. 2008;9:98
  21. Guiliano APJ, Male Quadrivalent HPV Vaccine Efficacy Trial Group. The efficacy of the quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV infection and HPV-related genital disease in young men. Abstract TC 2–11. Nice, France: European Research Organization on Genital Infection and Neoplasia (EUROGIN); 2008.
  22. Baker L, Wagner TH, Singer S, Bundorf MK. Use of the Internet and e-mail for health care information: results from a national survey. JAMA. 2003;289:2400–2406
  23. Bleakley A, Hennessy M, Fishbein M. Public opinion on sex education in US schools. Arch Pediatr Adolesc Med. 2006;160:1151–1156
  24. Davis MM, Fant K. Coverage of vaccines in private health plans: what does the public prefer?. Health Aff (Millwood). 2005;24:770–779
  25. Middleman AB. Adolescent immunizations: policies to provide a shot in the arm for adolescents. J Adolesc Health. 2007;41:109–118

PII: S1876-2859(09)00104-1

doi: 10.1016/j.acap.2009.04.004

Academic Pediatrics
Volume 9, Issue 5 , Pages 348-352 , September 2009

Article Tools